It triggers insulin release from the pancreas, aiding glucose absorption. It lowers glucose production in the liver and improves insulin sensitivity in peripheral tissues. It is an alpha-glucosidase inhibitor, that slows carbohydrate digestion, limiting postprandial glucose spikes.

• Follow your doctors' guidance for this medicine, taking it in the prescribed dose and duration.
• This medicine can be taken before or after having a meal, but one should maintain consistency for better results.
• Swallow the drug whole; avoid chewing, crushing, or breaking it.

• It increases insulin release, which can lead to hypoglycemia (low blood sugar).
• Avoid using higher dose as it may pose the risk of hypoglycaemia.
• Closely monitor the blood sugar levels and try to recognise the signs and symptoms associated with hypoglycaemia.
• Combining this drug with glimepiride may increase the risk of side effects.

• Triple combination for type 2 diabetes .
• Glimepiride stimulates insulin release .
• Metformin improves insulin sensitivity.
• Voglibose delays glucose absorption.

• Hypoglycemia (low blood glucose level)
• Dizziness
• Headache
• Nausea
• Weight gain
• Gastrointestinal disturbance
• Diarrhea
• Bellyache